413 related articles for article (PubMed ID: 30544079)
1. Cryptococcal meningitis in a multiple sclerosis patient treated with Fingolimod: a case report and review of imaging findings.
Chong I; Wang KY; Lincoln CM
Clin Imaging; 2019; 54():53-56. PubMed ID: 30544079
[TBL] [Abstract][Full Text] [Related]
2. Cryptococcal meningitis after fingolimod discontinuation in a patient with multiple sclerosis.
Ward MD; Jones DE; Goldman MD
Mult Scler Relat Disord; 2016 Sep; 9():47-9. PubMed ID: 27645342
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus (HCV) reactivation during fingolimod treatment for relapsing and remitting multiple sclerosis.
Tagawa A; Ogawa T; Tetsuka S; Otsuka M; Hashimoto R; Kato H; Ando K; Tanabe H
Mult Scler Relat Disord; 2016 Sep; 9():155-7. PubMed ID: 27645365
[TBL] [Abstract][Full Text] [Related]
4. Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literature.
Grebenciucova E; Reder AT; Bernard JT
Mult Scler Relat Disord; 2016 Sep; 9():158-62. PubMed ID: 27645366
[TBL] [Abstract][Full Text] [Related]
5. Cryptococcal meningoencephalitis in an IgG
Wienemann T; Müller AK; MacKenzie C; Bielor C; Weyers V; Aktas O; Hartung HP; Kremer D
BMC Neurol; 2020 Apr; 20(1):158. PubMed ID: 32340606
[TBL] [Abstract][Full Text] [Related]
6. Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis.
Christopher KL; Elner VM; Demirci H
Ophthalmic Plast Reconstr Surg; 2017; 33(3):e73-e75. PubMed ID: 27533512
[TBL] [Abstract][Full Text] [Related]
7. Necrotizing fungal osteomyelitis and fingolimod, 4 years after treatment with fingolimod.
Harirchian MH; Poursadeghfard M; Sadeghipour A; Kamali H; Sarraf P
Mult Scler Relat Disord; 2020 Jun; 41():102021. PubMed ID: 32126512
[TBL] [Abstract][Full Text] [Related]
8. Mycosis fungoides - A cutaneous lymphoproliferative disorder in a patient treated with fingolimod for multiple sclerosis.
Nitsan Z; Kucuk N; Appel S; Tichmanovich N; Osherov M; Milo R
J Clin Neurosci; 2018 Feb; 48():102-103. PubMed ID: 29108666
[TBL] [Abstract][Full Text] [Related]
9. Kaposi sarcoma in a fingolimod-treated patient with multiple sclerosis.
Walker S; Brew B
J Clin Neurosci; 2016 Sep; 31():217-8. PubMed ID: 27168454
[TBL] [Abstract][Full Text] [Related]
10. Fingolimod as an effective therapeutic strategy for pediatric relapsing-remitting multiple sclerosis: two case reports.
Zanetta C; Filippi M; Moiola L
Neurol Sci; 2021 May; 42(Suppl 1):9-13. PubMed ID: 33904006
[TBL] [Abstract][Full Text] [Related]
11. Glioblastoma following treatment with fingolimod for relapsing-remitting multiple sclerosis.
Sharim J; Tashjian R; Golzy N; Pouratian N
J Clin Neurosci; 2016 Aug; 30():166-168. PubMed ID: 26970935
[TBL] [Abstract][Full Text] [Related]
12. A Case of Fingolimod-associated Cryptococcal Meningitis.
Darazam IA; Rabiei MM; Moradi O; Gharehbagh FJ; Roozbeh M; Nourinia R; Hatami F; Shojaei M; Lotfollahi L
Curr HIV Res; 2022; 20(4):337-342. PubMed ID: 35770404
[TBL] [Abstract][Full Text] [Related]
13. Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study.
Ordoñez-Boschetti L; Rey R; Cruz A; Sinha A; Reynolds T; Frider N; Alvarenga R
Adv Ther; 2015 Jul; 32(7):626-35. PubMed ID: 26170105
[TBL] [Abstract][Full Text] [Related]
14. Cryptococcal meningitis causing obstructive hydrocephalus in a patient on fingolimod.
Pham C; Bennett I; Jithoo R
BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28687690
[TBL] [Abstract][Full Text] [Related]
15. Fingolimod hydrochloride for the treatment of relapsing remitting multiple sclerosis.
Thomas K; Proschmann U; Ziemssen T
Expert Opin Pharmacother; 2017 Oct; 18(15):1649-1660. PubMed ID: 28844164
[TBL] [Abstract][Full Text] [Related]
16. Real-World Outcomes in Fingolimod-Treated Patients with Multiple Sclerosis in the Czech Republic: Results from the 12-Month GOLEMS Study.
Tichá V; Kodým R; Počíková Z; Kadlecová P
Clin Drug Investig; 2017 Feb; 37(2):175-186. PubMed ID: 27785735
[TBL] [Abstract][Full Text] [Related]
17. Study design of PANGAEA 2.0, a non-interventional study on RRMS patients to be switched to fingolimod.
Ziemssen T; Kern R; Cornelissen C
BMC Neurol; 2016 Aug; 16():129. PubMed ID: 27502119
[TBL] [Abstract][Full Text] [Related]
18. A case of dextrocardia following maternal exposure to generic Fingolimod during the first trimester of pregnancy.
Navardi S; Sahraian MA
Mult Scler Relat Disord; 2018 Apr; 21():69-70. PubMed ID: 29474980
[TBL] [Abstract][Full Text] [Related]
19. Fingolimod-related cryptococcal meningoencephalitis and immune reconstitution inflammatory syndrome in a patient with multiple sclerosis.
Cuascut FX; Alkabie S; Hutton GJ
Mult Scler Relat Disord; 2021 Aug; 53():103072. PubMed ID: 34139459
[TBL] [Abstract][Full Text] [Related]
20. Systematic literature review and network meta-analysis in highly active relapsing-remitting multiple sclerosis and rapidly evolving severe multiple sclerosis.
Huisman E; Papadimitropoulou K; Jarrett J; Bending M; Firth Z; Allen F; Adlard N
BMJ Open; 2017 Mar; 7(3):e013430. PubMed ID: 28283486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]